Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Bodner

Showing results (81-90 of 88) with videos related to

Pageof 9
Sort By:
You have reached the last page of results.This site can display upto 88 results.
Lancet (London, England)|September 7, 1985
ELISA HTLV retrovirus antibody reactivity associated with malaria and immune complexes in healthy AfricansR J Biggar, P L Gigase, M Melbye, et al.
Journal of Natural Products|May 1, 1990
Anti-AIDS agents, 2: Inhibitory effects of tannins on HIV reverse transcriptase and HIV replication in H9 lymphocyte cellsG Nonaka, I Nishioka, M Nishizawa, et al.
Journal of Medicinal Chemistry|June 1, 1982
Carbocyclic analogue of 3-deazaadenosine: a novel antiviral agent using S-adenosylhomocysteine hydrolase as a pharmacological targetJ A Montgomery, S J Clayton, H J Thomas, et al.
JAMA|March 15, 1985
Frequent transmission of HTLV-III among spouses of patients with AIDS-related complex and AIDSR R Redfield, P D Markham, S Z Salahuddin, et al.
Lancet (London, England)|September 29, 1984
Determinants of retrovirus (HTLV-III) antibody and immunodeficiency conditions in homosexual menJ J Goedert, M G Sarngadharan, R J Biggar, et al.
ACS Chemical Biology|September 14, 2013
Reducing levels of toxic RNA with small moleculesLeslie A Coonrod, Masayuki Nakamori, Wenli Wang, et al.
JAMA|April 25, 1986
Human T-cell lymphotropic virus type III infection in a cohort of homosexual men in New York CityC E Stevens, P E Taylor, E A Zang, et al.
Science (New York, N.Y.)|November 6, 2010
The major genetic determinants of HIV-1 control affect HLA class I peptide presentation, Florencia Pereyra, Xiaoming Jia, et al.
Pageof 9

Showing results (81-90 of 88) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 88 results.
Lancet (London, England)|September 7, 1985
ELISA HTLV retrovirus antibody reactivity associated with malaria and immune complexes in healthy AfricansR J Biggar, P L Gigase, M Melbye, et al.
Journal of Natural Products|May 1, 1990
Anti-AIDS agents, 2: Inhibitory effects of tannins on HIV reverse transcriptase and HIV replication in H9 lymphocyte cellsG Nonaka, I Nishioka, M Nishizawa, et al.
Journal of Medicinal Chemistry|June 1, 1982
Carbocyclic analogue of 3-deazaadenosine: a novel antiviral agent using S-adenosylhomocysteine hydrolase as a pharmacological targetJ A Montgomery, S J Clayton, H J Thomas, et al.
JAMA|March 15, 1985
Frequent transmission of HTLV-III among spouses of patients with AIDS-related complex and AIDSR R Redfield, P D Markham, S Z Salahuddin, et al.
Lancet (London, England)|September 29, 1984
Determinants of retrovirus (HTLV-III) antibody and immunodeficiency conditions in homosexual menJ J Goedert, M G Sarngadharan, R J Biggar, et al.
ACS Chemical Biology|September 14, 2013
Reducing levels of toxic RNA with small moleculesLeslie A Coonrod, Masayuki Nakamori, Wenli Wang, et al.
JAMA|April 25, 1986
Human T-cell lymphotropic virus type III infection in a cohort of homosexual men in New York CityC E Stevens, P E Taylor, E A Zang, et al.
Science (New York, N.Y.)|November 6, 2010
The major genetic determinants of HIV-1 control affect HLA class I peptide presentation, Florencia Pereyra, Xiaoming Jia, et al.
Pageof 9